Navigation Links
net in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...egy and as a result reported $669,000 of pro forma net income for the quarter ended June 30, 2009, a sign...ame period in 2008. Isis also reported a pro forma net operating loss of $1.3 million for the second quarter compared to pro forma net operating income of $4.6 million for the same peri...

NewCardio Announces Master Services Agreement With Dedicated Phase I

...provide. In addition, we can reduce study timelines by several weeks, providing significant savings to customers on the overall cost of the study. The net result is that sponsors will receive higher quality study results and also save time and money. This is a win-win for Dedicated Phase I and our custom...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...or the second quarter ended June 30, 2009. net loss for the quarter ended June 30, 2009 was $32.1 million or $0.35 per share, compared to net loss of $33.4 million or $0.36 per share in the se...29) (6,285) (7,847) Other income, net 203 769 248 1,071 ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

...sitions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&...

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

...uman and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

..., product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share. Statements including words such as "...

New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%

...y triglycerides and promotes digestive health," says Chronister. "This latest study strongly suggests that a very potent overall health benefit is the net result of adding prebiotics to the diet." A precis of the research is presented at http://www.prebiotin.com , as well as a link to the full ...

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

...the collaboration Shire will pay development and sales milestones up to a maximum of $390 million, and will also pay tiered, double digit royalties on net sales of the products. Shire also shares world-wide development costs on a 50/50 basis, and in return Shire received rights to commercialize these pro...

VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers

...wear the garment. Numerous studies confirm the potential of RPM initiatives to improve outcomes for patients with chronic diseases and reduce the net cost of their care. It is estimated that savings resulting from RPM will reach $200 billion over the next 25 years in the United States alone(1). Howe...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

...sitions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&...

Boehringer Ingelheim Unveils Diabetes Pipeline

...or human and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

...s on sales elsewhere in the world. If Celtic Pharma sells or licenses the commercialization rights to XERECEPT, NTI is entitled to a percentage of the net proceeds received by Celtic. NTI has not reviewed the data from the clinical trials or the preclinical studies and cannot independently corrobora...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

...atment-naive, had locally inoperable or metastatic net with the primary tumor located in the midgut, were... in the endocrine and nervous systems. While these net are often slow-growing, when the tumor is inoperable patients with advanced net have limited treatment options(2). The safety...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

...percent lower than CABG at one year (8,295 pounds Sterling PCI vs. 11,101 pounds Sterling CABG, p<0.001). The lower medical costs coupled with the net improvement in quality of life resulted in PCI as the dominant treatment strategy at one year. Results further showed that although the average ...

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

... exceeds $350,000. In addition to the purchase price payable at closing, Pierrel will pay Encorium a 10% commission on the value of any new contract, net of pass-through costs, executed after the closing date but prior to December 31, 2009, which constitute part of the Company's pipeline at closing. ...

DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms

...on and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents....

Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009

...or human and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of $17 billion (11.6 billion euro) while spending one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Spherix Reports First Quarter 2009 Earnings

... the first quarters ended 2009 and 2008. The net loss for the quarter ended March 31, 2009 was $2.0 million or $0.14 per share, compared with a net loss of $1.9 million or $0.13 per share for the sa... --- --- net loss $(2,066,084...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

...ses in professional fees and operating costs. net loss for the quarter ended March 31, 2009, was $9.3 million, or $0.24 per share, compared to a net loss for the quarter ended March 31, 2008, of $13....llion. BioCryst continues to expect the Company's net cash use in 2009 will be between $30.0 and $38.0 m...

Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery

...artis is the only company with leading positions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland,...

Bionovo Announces First Quarter 2009 Highlights and Financial Results

...in the second quarter. The Company reported a net loss for the three months ended March 31, 2009 of $4.7 million, or $0.06 per share, compared with a net loss of $3.9 million, or $0.05 per share, for the ... (79) (19) (156) net loss $(4,668) $(3,94...

Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status

...provided an update on its product candidates. The net loss for the quarter, as reported in accordance wi...ited States (GAAP), was $6.9 million compared to a net loss of $18.4 million in the comparable period in ...educe its expenses by approximately $21.5 million, net of severance costs, for fiscal year 2009, compared...

InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients

... minimizing arterial injury, this promising technology can be an effective and uniform drug delivery mechanism with the help of the novel micron-level net for next generation drug eluting stents. InspireMD intends to pursue applications of this technology both for bare metal and drug eluting stents in co...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

...ed Financial Results The Company reported a net loss of $13.0 million ($0.38 diluted loss per shar...r the quarter ended March 31, 2009 compared with a net loss of $9.9 million ($0.29 diluted loss per share... ------- ------- Other income (expense), net (706) 664 ...

New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting

...or human and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

...t in part by associated severance costs. net Loss Attributable to Lexicon Pharmaceuticals, Inc.: net loss for the three months ended March 31, 2009 was $21.6 million, or $0.16 per share, compared to a net loss of $18.0 million, or $0.13 per share, in the ...

SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production

...nes. Vivalis receives up front, milestones, and royalties on its licensees' net sales. 2. The development of production systems for recombinant protei...ies. Vivalis receives up front, milestones, and royalties on its licensees' net sales. 3. The construction of a portfolio of proprietary products in t...

Prometheus and Rosetta Genomics Announce License and Collaboration Agreement

...rms of the license agreement provide for payments to Rosetta, either as milestones or research and development funding, as well as royalty payments on net sales in the U.S. Under the terms of a separate stock purchase agreement, Prometheus will also make an equity investment in Rosetta of $8 million at $...

MedNet Solutions Certified to Score SF-12v2 Health Survey

...., PhD is a thought-leader in the field of psychometrics and health outcome measurement. Visit us at www.qualitymetric.com . Abo u t Me d net Solution s : MedNet Solutions is a global healthcare technology company specializing in clinical study management systems designed for the global...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

...sitions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease

...xity, PCI was favored, providing more quality-adjusted life years and lower net medical costs than CABG. For patients with the most complex disease -- and...lightly more quality-adjusted life years, with no significant difference in net medical costs at one year. The results showed that both PCI and CABG...

A Joint Statement From America's Prostate Cancer Advocacy, Education, and Support Organizations

...rg * Prostate Health Education Network - www.prostatehealthed.org * The Prostate Cancer Mission - www.pcmission.org * The Prostate net - www.prostatenet.org * Us TOO International Prostate Cancer Education and Support Network - www.ustoo.com * Virginia Prostate Cancer Co...

InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation

... aiding collaboration and the spread of knowledge. For large global challenges like infectious diseases and climate change, it makes sense to cast the net as wide as possible to find experts who can solve a problem," said Steven Inchcoombe, Managing Director, Nature Publishing Group. "Through this partne...

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

...n its sole discretion, issue additional ordinary shares to Bio-GAL Ltd in lieu of such milestone payment. XTL is also obligated to pay 1% royalties on net sales of the product. The closing of the transaction is subject to various conditions including XTL's and Bio-GAL's shareholders' approvals, as well ...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

... drew down approximately $20 million of additional net cash proceeds under the Company's amended and rest...r 2008 Financial Results The Company reported a net loss of $13.9 million ($0.41 diluted loss per shar...on) for the fourth quarter of 2008 compared with a net loss of $9.6 million ($0.28 diluted loss per share...

Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients

...lth economic analysis of the Swedish study has also been published and concluded that routine prophylactic use of the Gentamicin Implant resulted in a net cost saving per patient. Patient enrolment in a second phase 3 trial being conducted in patients undergoing open colorectal surgery is expected t...

DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology

...on and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents....

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

...B agreement with GSK. The Company reported a net loss for 2008 of $244.9 million ($1.81 per share), compared with a net loss of $262.4 million ($1.95 per share) for 2007. The decreased net loss for 2008 was due primarily to a gain on the s...

From eResearchTechnology to ERT

... to 2008 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, inte...

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

...evelopment and commercialization of potential products resulting from this collaboration, as well as undisclosed royalties on the associated worldwide net sales. Ambrx also retains the option to convert its right to receive royalties in the U.S. to a profit and loss sharing option. If the option is exerc...
Other Tags
(Date:6/23/2015)... , June 22, 2015 ... announced the addition of the "Body-Worn Temperature ... Growth, Trends and Forecast 2014 - 2020" ... offers strategic analysis of the global body-worn temperature ... has been segmented on the basis of types, ...
(Date:6/18/2015)... June 18, 2015 This report analyzes the ... the following Product Segments, which includes Immunoassay Analyzers and ... Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The ... Canada , Japan , ... , Latin America , and Rest ...
(Date:6/17/2015)... and HILDEN, Germany , June 17, 2015 ... Frankfurt Prime Standard: QIA) today launched new Investigator ® ... laboratories in the United States . The ... analyze multiple key genomic markers (short tandem repeats or STRs) ... Sensor to evaluate the quality of DNA in each sample, ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
(Date:7/2/2015)... , ... July 02, 2015 , ... ... to healthcare providers, has been retained to lead a national chief operating ... top executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/2/2015)... ... ... AvePoint Public Sector, Inc., a wholly owned subsidiary of AvePoint, ... was named the recipient of the 2015 GTRA ConVurge Tech Award for Excellence in ... Technology Research Alliance (GTRA), was presented June 29 during the ConVurge Honorary Awards dinner ...
(Date:7/2/2015)... ... , ... As the world becomes more connected through the Internet, not only ... in their everyday lives. Technology can now help homeowners gain more control of their ... as well as making kitchen tasks simpler. , "Summer is a great ...
(Date:7/2/2015)... ... July 02, 2015 , ... A Board ... CoolSculpting Plus, an advanced approach to body contouring. CoolSculpting Plus combines CoolSculpting® ... About the basic CoolSculpting procedure:, The CoolSculpting procedure is the only ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... nutritionally based weight-loss programs , was named No. 14 on ColoradoBiz magazine’s Top ... the third year SlimGenics has been recognized. The award identifies outstanding woman-owned businesses ...
Breaking Medicine News(10 mins):Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 2Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 4Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3
Other Contents